DNA Methylation-Independent Reversion of Gemcitabine Resistance by Hydralazine in Cervical Cancer Cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA Methylation-Independent Reversion of Gemcitabine Resistance by Hydralazine in Cervical Cancer Cells
Authors
Keywords
DNA methylation, Histones, Methyltransferases, Cervical cancer, Gene expression, Polymerase chain reaction, Epigenetics, Acetylation
Journal
PLoS One
Volume 7, Issue 3, Pages e29181
Publisher
Public Library of Science (PLoS)
Online
2012-03-13
DOI
10.1371/journal.pone.0029181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA and drug resistance
- (2010) J Ma et al. CANCER GENE THERAPY
- Histone Methyltransferase MLL1 Regulates MDR1 Transcription and Chemoresistance
- (2010) H. Huo et al. CANCER RESEARCH
- SIRT2 downregulation confers resistance to microtubule inhibitors by prolonging chronic mitotic arrest
- (2010) Toshiaki Inoue et al. CELL CYCLE
- Influence of Cytidine Deaminase on Antitumor Activity of 2'-Deoxycytidine Analogs In Vitro and In Vivo
- (2010) T. Yoshida et al. DRUG METABOLISM AND DISPOSITION
- Protein Lysine Methyltransferase G9a Inhibitors: Design, Synthesis, and Structure Activity Relationships of 2,4-Diamino-7-aminoalkoxy-quinazolines.
- (2010) Feng Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Methylation Specific PCR to Characterize Methylation of the Promoter of Deoxycytidine Kinase
- (2010) G. J. Peters et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Structural Biology of Human H3K9 Methyltransferases
- (2010) Hong Wu et al. PLoS One
- Molecular Modeling and Molecular Dynamics Studies of Hydralazine with Human DNA Methyltransferase 1
- (2009) Narender Singh et al. ChemMedChem
- Clinical pharmacology and pharmacogenetics of gemcitabine
- (2009) Andrea Wong et al. DRUG METABOLISM REVIEWS
- Hypothesizing that histone deacetylase inhibitors can be used to reverse multiple drug resistance
- (2009) Zhi-Ping Jiang et al. MEDICAL HYPOTHESES
- Pharmacogenetics and pharmacoepigenetics of gemcitabine
- (2009) M. Candelaria et al. MEDICAL ONCOLOGY
- Association between CpG Island Methylation of the WWOX Gene and Its Expression in Breast Cancers
- (2009) X. Wang et al. TUMOR BIOLOGY
- Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine
- (2008) J Souglakos et al. BRITISH JOURNAL OF CANCER
- Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression
- (2008) Yinhong Song et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Regulation of Pancreatic Tumor Cell Proliferation and Chemoresistance by the Histone Methyltransferase Enhancer of Zeste Homologue 2
- (2008) A. V. Ougolkov et al. CLINICAL CANCER RESEARCH
- Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells
- (2008) Alice Y.S. Law et al. EXPERIMENTAL CELL RESEARCH
- Silencing of the Candidate Tumor Suppressor Gene Solute Carrier Family 5 Member 8 (SLC5A8) in Human Pancreatic Cancer
- (2008) Jong Y. Park et al. PANCREAS
- Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients
- (2008) Ioannis Boukovinas et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started